Showing all 3 results
Desloratidine Tablets
FreeProduct Composition & Strength
We supply this product as a Precision-Blended, Rapid-Dissolution Film-Coated Tablet, packed exclusively in highly secure, moisture-resistant Alu-PVC or Alu-Alu blister strips to ensure the absolute chemical stability of the highly potent API.
Active Ingredient Strength Primary Clinical Function Desloratadine USP/Ph.Eur. 5 mg The Global Allergy & Dermatology Anchor: The definitive once-daily therapeutic unit utilized for the continuous, 24-hour baseline control of Allergic Rhinitis (Hay Fever) and severe Chronic Urticaria. Excipients Microcrystalline Cellulose / Dibasic Calcium Phosphate / Maize Starch / Talc / Premium Polymeric Film Diluent / Densifier / Disintegrant / Glidant / Heavy Film-Coating (Engineered specifically utilizing elite rapid-burst disintegrants to ensure the tablet shatters instantly in gastric fluid. The dense polymer coating masks the inherent bitterness of the API, ensuring a flawless patient experience) *Pack Sizes: 10×10 Blisters or Bottles of 30 (Optimized specifically for strict, 30-day chronic allergy and dermatology dispensing regimens).
Entacavir Tablets
FreeProduct Composition & Strength
We supply this product as a Precision-Blended, High-Density Microdose Tablet, packed exclusively in highly secure, moisture-resistant Alu-Alu blister strips or heavy-gauge HDPE bottles to ensure the absolute chemical stability of the potent antiviral API.
Active Ingredient Strength Primary Clinical Function Entecavir (as Monohydrate) USP/Ph.Eur. 0.5 mg The Global Nucleoside-Naive Standard: The definitive ultra-micro-dose utilized for the daily, lifelong suppression of HBV in patients who have never received prior antiviral therapy. Entecavir (as Monohydrate) USP/Ph.Eur. 1.0 mg The Refractory & Cirrhosis Standard: Double-strength therapeutic payload utilized specifically for patients with Lamivudine-resistant HBV viremia or those suffering from decompensated liver cirrhosis. Excipients Lactose Monohydrate / Microcrystalline Cellulose / Crospovidone / Magnesium Stearate / Premium Polymeric Film Diluent / Binder / Superdisintegrant / Lubricant / Film-Coating (Engineered specifically utilizing advanced multi-stage geometric dilution to ensure the microscopic 0.5mg payload is flawlessly distributed throughout the tablet matrix, preventing toxic “hot spots” or sub-therapeutic failures) *Pack Sizes: 3×10 Alu-Alu Blisters or Bottles of 30 (Optimized specifically for strict 30-day chronic hepatology dispensing regimens).
Moxonidine Tablets
FreeProduct Composition & Strength
We supply this product as a Precision-Blended, Micro-Dosed Film-Coated Tablet, packed exclusively in highly secure, moisture-resistant Alu-PVC or Alu-Alu blister strips to ensure the absolute chemical stability of the active ingredient.
Active Ingredient Strength Primary Clinical Function Moxonidine Ph.Eur./BP 0.2 mg Initiation / Mild Standard: Base therapeutic unit for starting therapy, specifically titrated to assess patient tolerance and prevent initial hypotension. Moxonidine Ph.Eur./BP 0.3 mg / 0.4 mg Global Cardiology Standard: High-efficacy adult maintenance dose for the aggressive management of resistant and metabolic hypertension. Excipients Lactose Monohydrate / Povidone K30 / Crospovidone / Magnesium Stearate / Premium Opadry Film Diluent / Binder / Superdisintegrant / Lubricant (Engineered specifically using strict geometric dilution protocols to ensure the microscopic API dose is flawlessly and evenly distributed throughout the entire tablet batch) *Pack Sizes: 10×10 Blisters or 28/30-Tablet Calendar Packs (Optimized specifically for strict chronic cardiology dispensing regimens).
